Last updated on June 2018

A Study to Evaluate the Safety and Efficacy of AstroStem in Treatment of Alzheimer's Disease


Brief description of study

This is a randomized, double-blind, placebo-controlled, parallel-group comparison study in subjects with Alzheimer's Disease. Following first screening period, subjects will be randomly assigned into one of the following arms: AstroStem and placebo control in a 1:1 ratio. AstroStem or placebo control will be administered via I.V. at Week 0. This procedure will be repeated 9 times at 2-week interval. Subjects will be scheduled for two follow-up visits at Weeks 30 and 52 to evaluate primary and secondary outcome endpoints.

Clinical Study Identifier: NCT03117738

Contact Investigators or Research Sites near you

Start Over

ATP Clinical Research

Costa Mesa, CA United States
  Connect »

Syrentis Clinical Research

Santa Ana, CA United States
  Connect »

Valden Medical

Honolulu, HI United States
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.